1 synthesis directed towards agelasines, agelasimines, asmarines and analogs; bioactive marine...
TRANSCRIPT
![Page 1: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/1.jpg)
1
Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs;
Bioactive Marine Natural Products
Lise-Lotte Gundersen
Department of Chemistry, University of Oslo, Norway
![Page 2: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/2.jpg)
2
23. Organisk-kjemiske vintermøte, Geilo 2008
21:a Organikerdagarna, Åhus 2008
![Page 3: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/3.jpg)
3
Marine organisms Algae and invertebrates (sponges, mollusks, tunicates etc)
Rich sources of bioactive compounds - Defence
•Antimicrobial
•Antineoplastic
![Page 4: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/4.jpg)
4
Nature 2004, 430, 242
Nature 2004, 431, 892:
“Antibiotics are the worst
sort of pharmaceuticals
because they cure the
disease”
![Page 5: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/5.jpg)
5
Agelasines Agelasimines Asmarines
N
N N
N
NHO
H
Asmarine A
N
N N
N
N
Agelasimine A
OH
H
Purine-Containing Natural Productsfrom Marine Sponges
•Total synthesis
•Synthesis of analogs
•Bioactivities
H
N
N N
N
NH2
Cl
Agelasine A
![Page 6: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/6.jpg)
6
Marine Sponges?
![Page 7: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/7.jpg)
7
Agelasines
•Isolated from marine sponges (Agelas sp.)
•11 comp. (Agelasine A - I, epiagelasine C and ageline B) known to date
•Total syntheses other groups: Agelasine A, B and C, and (±) agelasine F
•Bioactivities:
Cytotoxic
Antimicrobial
etc.
Brown Tube Sponge: Agelas sp. 2.5 feet long
H
N
N N
N
NH2
Cl
Agelasine A
7,9-dialkylated Adeninium salt
Terpenoid side chain at N-7
![Page 8: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/8.jpg)
8
Synthesis of Trixagol and Agelasine E
Trixagol
OH
Isolated from Bellardia trixagoTL, 1978, 3491Isolated from Agelas sp.
Tetrahedron Lett. 1984, 2989
N
N N
N
NH2
CH3
CO2H
OH
Agelasine E
Geraniol
N
N NH
N
NH2
Helv. Chim. Acta, 1995, 539
Adenine
Cl
![Page 9: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/9.jpg)
9
Synthesis of Trixagol and ent-Trixagol
Bakkestuen et al., Tetrahedron 2003, 59, 115
HO2C
HO2C
HO2C
O
H3CO2C
OOOCH3
OCH3
O
O
4 steps
+c.f. lit.
Synth. rac. acid: Helv. Chim. Acta, 1952, 1752 Resolution:Helv. Chim. Acta. 1995, 539
c.f. lit.
Trixagol
ent-Trixagol
Agelasine E
OH
3 steps
HO2C Litt. HOPhSSPh
Bu3P
pyridine
PhS
(S) 90%(R) 91%
oxone
MeOH, H2O0 oC
OTHP
OTHP
SO2Ph
PhSO2
OTs
OTHP
n-BuLiDMPU
THF
Na, Na2HPO4EtOH, THF
(S) 39%(R) 41%
two steps
PPTS
EtOH, 55 oC
OH
(S) 73% Trixagol(R) 82%
(S) 81%(R) 86%Tetrahedron 1997, 53, 3527
![Page 10: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/10.jpg)
10
Synthesis of Agelasine E and ent-Agelasine E
N
N N
N
NH2
R
N
N N
N
NH
R
R'N
N N
N
NH2 R
N
N N
N
NH R
R'
Regioselectivity in dialkylation of adenines
R'X R'X
Bakkestuen et al., Org. Biomol. Chem. 2005, 3, 1025
N
N N
N
Cl
HN
N N
N
NMeO
N
N N
N
NMeO
N
N N
N
NMeO
+
MeONH3Cl, Et3N
n-BuOH, Δ63%
DMA, 50 oC
1) Zn, AcOHMeOH / H2O
2) NaCl(aq)Cl
(R) Enantiomer shown(S), Trixagol
OH
82% (R)96% (S)
BrPBr3
Et2O, 0 oC
N
N N
N
NH2
48% (R)44% (S)
32% (R)26% (S)
54% (R) Agelasine E89% (S)
HN
N N
N
N
R
CH3O
HN
N N
N
N
R
CH3OR'
R'X N
N N
N
N
R
CH3O R'
+X
![Page 11: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/11.jpg)
11
Synthesis of Agelasine D
Agelasine D Manool
Sclareol
Salvia sclarea (Clary Sage)
Isolated from Agelas sp.Tetrahedron Lett. 1984, 2989
N
N N
N
NH2
H
H
X
H
HO
H
HO
OHCl
![Page 12: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/12.jpg)
12
Synthesis of Agelasine D - Initial Approach
Drawbacks: Lack of selectivity
Utenova et al., Tetrahedron Lett. 2004, 45, 4233
H
Br
HN
N N
N
NMeO
N
N N
N
N
N
N N
N
NMeO
+
DMA, 50 oC
Zn, AcOH
MeOH, H2O
H
N
N N
N
NH2
H
MeO
H
60% E:Z 8:243% pure E after cryst.
27% E:Z 8:2
Cl
51%81% E:Z 8:2
PBr3, pyridine
Et2O, -35 oC
H
HO
(+) Manool
(+) Agelasine D
![Page 13: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/13.jpg)
13
Improved Synthesis of Agelasine D
Synthesis of geometrically pure allyl bromide
Vik et al., J. Nat. Prod. 2006, 69, 381
H
AcO
90% E:Z 92:8
Ac2O, DMAP, Et3N
THF, Δ
H
AcO
PdCl2(MeCN)2
THF, 0 oC
K2CO3
MeOH
H
HO
76% Pure E
PBr3, pyridine
Et2O, 0 oC
H
Br
76% Pure E
Anticopalol
H
Br
81% E:Z 8:2
PBr3, pyridine
Et2O, -35 oC
H
HO
(+) Manool
![Page 14: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/14.jpg)
14
Improved Synthesis of Agelasine D - Regioselective N-alkylation
Vik et al., J. Nat. Prod. 2006, 69, 381
H
Br
HN
N N
N
NMeO
N
N N
N
N
N
N N
N
NMeO
+DMA, 50 oC
H
MeO
H
60% E:Z 8:2 27% E:Z 8:2
H
Br
HN
N N
N
NO
N
N N
N
N
DMA, 50 oC
Zn, AcOH
MeOH, H2O
H
N
N N
N
NH2
H
O
Cl
49%
(+) Agelasine D
90%
Only isomer observed
HN
N N
N
NRO
DMA, 50 oC
PhCH2Br N
N N
N
NRO Ph
A
+ N
N N
N
NRO
Ph
B
R- Ratio A : B Yield (%) A Yield (%) B
CH3- 60 : 40 55 30
t-Bu- 90 : 10 86 9
PhCH2- 80 : 20 72 13
![Page 15: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/15.jpg)
15
Synthesis of Agelasine F
Isolated from Agelas sp.Tetrahedron Lett. 1984, 2989J. Am. Chem. Soc. 1984, 106, 1819
N
N N
N
NH2
CH3
Agelasine F(Ageline A)
Cl
Asao et al., Synthesis 1990, 382Asao et al., Tetrahedron Lett. 1989, 30, 6397
Asao et al., Tetrahedron Lett. 1989, 30, 6401
O
CO2Me
BnOBr
+9 steps
(±)
HO
11 steps Br
(±)2 steps
(±) Agelasine F
![Page 16: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/16.jpg)
16
Synthesis of Agelasine F
Isolated from Agelas sp.
Isolated from pennyroyal
(Mentha Pulegium)
N
N N
N
NH2
CH3
Agelasine F(Ageline A)
Cl OH
Geraniol
N
N NH
N
X
X(S)-Pulegone
![Page 17: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/17.jpg)
17Proszenyak et al., Manuscript
BrO
(R)-Pulegone Side chain ent-Agelasine F
O
(R)-Pulegone
O TMSO
TMSCl, Et3N
DMF
1) LDA2) MeI
THF- 78 oC
O
KOH (aq)
48% from pulegone
Cl SPh
O
PhS
57%
O
PhS
33%
+TiCl4, CH2Cl2, -23 oC
TMSO
Cl SO2Ph
O
PhS
O
PhS
oxone
MeOH, H2OO
PhSO2
O
PhSO2
87%
85%
oxone
MeOH, H2O
X-ray; minor isomer sulfone
![Page 18: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/18.jpg)
18Proszenyak et al., Manuscript
PhSO2
PhSO2
Agelasine E Agelasine F
More reactive
O
PhSO21) MeMgI
Et2O, 0 oC - rt
82%
2) HCO2H, 80 oC
PhSO2
1) BuLi
2) THPO
THF, 50 oC
THPO
SO2Ph
THPONa, Na2HPO4
EtOH, THF
PPTs
EtOH, 55 oC
HO
I
54%(Two steps)
82%
PBr3
Et2O, 0 oCBr
93%
O
(R)-Pulegone
![Page 19: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/19.jpg)
19
Intermediate in synthesis of other natural products ?
O
(S)-Pulegone
O
O
O
OculatolideO
Subersin
S
NHH2N
HN
OO
(-) Agelasidine CAgelasidine D
OH
S
NHH2N
HN
O
O
PhSO2
O
(R)-Pulegone
O
O
O
Sollasin D
O
Sollasin A(Fulvanin 1)
O
S
NHH2N
HN
OO
S
HN
H2NNH
OO
(+) Agelasidine C
Agelasidine B
PhSO2
O
O
Microcionin 2
O
O
O
O
Striatol
OH
![Page 20: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/20.jpg)
20
Proszenyak et al., Manuscript
Asao et al., Synthesis 1990, 382Asao et al., Tetrahedron Lett. 1989, 30, 6397
Asao et al., Tetrahedron Lett. 1989, 30, 6401
BrO
10 steps
O
CO2Me
BnOBr
+9 steps
(±)
HO
11 steps Br
(±)
![Page 21: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/21.jpg)
21Proszenyak et al., Manuscript
O
(R)-Pulegone
Br
HN
N N
N
NRO
N
N N
N
NRO
76%, R = t-Bu
49%, R = Me
+ N
N N
N
NRO
11%, , R = t-Bu
23%, R = Me
N
N N
N
NH2
48%
Cl
DMA, 50 oC
ent-Agelasine F
Zn, AcOH
MeOH, H2O75 oC
![Page 22: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/22.jpg)
22
Bakkestuen et al., Org. Biomol. Chem. 2005, 3, 1025
Vik et al., J. Nat. Prod. 2006, 69, 381
Vik et al., Bioorg. Med. Chem. 2007, 15, 4016
Proszenyak et al., Arch. Pharm. Chem. Life Sci. 2007, 340, 625
HN
N N
N
N
R''
RO
orHN
N N
N
N
R''
OR
syn anti
HN
N N
N
NMeO
H2N
OHO
HO
NOE
Hill et al. Nucl. Acids Res. 1998, 26, 1144
HN
N N
N
N
R''
RO
HN
N N
N
N
R''
RO R'
N
N N
N
NH2
R''
R'
ClR'-CH2-Br
N
N N
N
NH
R''
RO
A
B
RONH2N
N N
N
Cl
R''
R''XN
N NH
N
Cl[red]
Base
N
N N
N
N
R''
RO R'
X
HX
1H NMR: A : B, ca 8 : 2 (CDCl3, CD3OD, DMSO-d6), 25 oC
Only minor variations depending on R and R''
![Page 23: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/23.jpg)
23
X % Amine B in DMSO-d6
40 oC25 oC 70 oC
H 20 25 32
Me 18 21 29
CF3 100 100 100
Cl 100 100 100
NO2 100 100 100
OMe 92 92 92
OEt 94 93 94
NHMe 28 33 37
NMe2 100 100 100
1H NMR data Roggen et al. Manuscript
N
N
Cl
X N
N
Me
N
N
NH
X N
N
Me
MeO
HN
N
N
X N
N
Me
MeO
H, CH3, CF3, Cl, NO2 H, CH3, CF3, Cl, NO2
OMe, OEt, NHMe, NMe2
A B
MeONH2
HXR
![Page 24: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/24.jpg)
24Roggen et al. Manuscript
X Yield (%) 1 Yield (%) 2
H 51 35
Me 57 29
CF3 <2 _
Cl 4 _
NO2_ _
OMe _11
OEt 52 20
NHMe 61 7
NMe2 56 22
Yields of isolated compounds
% Start. mat. recov
8
5
66
86
95
14
22
12
_
N
N
NH
X N
N
Me
MeO
HN
N
N
X N
N
Me
MeO
H, Me, CF3, Cl, NO2
OMe, OEt, NHMe, NMe2
A B
HN
N N
N
N
Me
MeO
N
N N
N
N
Me
MeO
+
X X
Ph
BrBnBr
DMA, 50 oC
1 2
Ph
N
N N
N
NH
Me
MeO
19%
O
Ph**
![Page 25: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/25.jpg)
25
Bioactivities•Antibacterial (incl. Mycobacterium tuberculosis)•Antifungal•Antiprotozoal (incl. several causing tropical diseases;
i.e. Chagas disease, Viceral Leichmaniasis)•Antifouling•Antineoplastic
HN
N N
N
N
R''
RO
HN
N N
N
N
R''
RO R'
N
N N
N
NH2
R''
R'
ClR'-CH2-Br [red]
Base
N
N N
N
N
R''
RO R'
X
HX
X X X
X
Bakkestuen et al., Org. Biomol. Chem. 2005, 3, 1025
Vik et al., J. Nat. Prod. 2006, 69, 381
Vik et al., Bioorg. Med. Chem. 2007, 15, 4016
Proszenyak et al., Arch. Pharm. Chem. Life Sci. 2007, 340, 625Sjögren et al., Biofouling. 2008, 24, 251
![Page 26: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/26.jpg)
26
•Generally broad spectrum activity
•Type A more active than type B structure ( otherwise same subst.)
•R’ must be relatively long and preferably contain unsaturation(s)
•R, R’’ and X; some modifications of activity spectrum
Structure - Activity Relationships
HN
N N
N
N
R''
RO R'
N
N N
N
NH2
R''
R'
XX X
Type A Type B
X
HN
N N
N
N
CH3
MeO
HO
geranylgeraniol
Agelasine analog
X
![Page 27: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/27.jpg)
27
WHO (1993): Tuberculosis - TB a “global emergency”
•AIDS
•Resistant strains
•Migration
•Powerty
Ca. 3 mill deaths / year
R MIC M. tuberculosis (μg/mL)
Type A Type B
3.13
1.56
3.13
3.13
n.d.
>6.25(38% inhib. at 6.25 μg/mL)
>6.25(21% inhib. at 6.25 μg/mL)
>6.25(30% inhib. at 6.25 μg/mL)Agelasine E
>6.25(38% inhib. at 6.25 μg/mL)
3.13Agelasine F
MIC Rifampin 0.25 μg/mL Bakkestuen et al., Org. Biomol. Chem. 2005, 3, 1025Mangalindan et al. Planta Med. 2000, 66, 364; Agelasine F
N
N N
N
NH2
Cl
R
N
N N
N
N RMeO
Type A Type B
![Page 28: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/28.jpg)
28Bakkestuen et al., Org. Biomol. Chem. 2005, 3, 1025Vik et al., Bioorg. Med. Chem. 2007, 15, 4016
N
N N
N
N
CH3
MeO
Staphylococcus aureus
MIC (μg/mL)
Mycobacterium tuberculosisMIC (μg/mL)
4.0 3.13
N
N N
N
N
CH3
MeO > 32 >6.25(86% inhib. at 6.25 μg/mL)
N
N N
N
NHMeO > 32 >6.25
(74% inhib. at 6.25 μg/mL)
N
N N
N
NH2
CH3
Cl
32 >6.25(38% inhib. at 6.25 μg/mL)
N
N N
N
NH2 > 32 1.56
![Page 29: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/29.jpg)
29Bakkestuen et al., Org. Biomol. Chem. 2005, 3, 1025Vik et al., Bioorg. Med. Chem. 2007, 15, 4016Vik et al., Planta Med. 2007, 73, 1410
N
N N
N
N
CH3
MeO
Staphylococcus aureus
MIC (μg/mL)
Mycobacterium tuberculosisMIC (μg/mL)
HO
(Geranylgeraniol)
O
O
O
4.0 3.1
3.1n.d.
> 32 1.6
n.d. n.d.(0% inhib. at 6.25 μg/mL)
![Page 30: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/30.jpg)
30
N
N N
N
NH2
H
Cl Sjögren et al., Biofouling. 2008, 24, 251
Antifouling activity - Barnacles
Agelasine D and analogs inhibit settlement of Balanus improvisus cypris larvae,
low tox. to cyprids
![Page 31: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/31.jpg)
31
Agelasines Agelasimines Asmarines
N
N N
N
NHO
H
Asmarine A
N
N N
N
N
Agelasimine A
OH
H
Purine-Containing Marine Natural Productsfrom Marine Sponges
H
N
N N
N
NH2
Cl
Agelasine A
![Page 32: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/32.jpg)
32
Asmarines
•Isolated from marine sponges (Raspailia sp.)
•11 comp. (Asmarine A - J)
•No total syntheses
•Bioctivities: Cytotox.
N
N N
N
NR
H
Asmarine A: R = OHAsmarine B: R = OH (epi at C'-5)Asmarine G: R = OMeAsmarine H: R = HAsmarine K: R = H (epi at C'-5)
N
N N
N
NR
H
O
* *
Asmarine D: R = OHAsmarine C: R = OH (epi at C'-5)Asmarine E: R = OMe (epi at C'-5)Asmarine F: R = OMe
N
N N
N
NR
H
Asmarine I: R = OHAsmarine J: R = H
![Page 33: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/33.jpg)
33
Previous strategies for construction of the 7-membered ring
No ex. of formation of bond c or d
N
N
N
N
NX
R1R2
a
b cd
e
N
N
N
N
Cl
HNMOM
N
HN
N
N
NRO
N
N
NH
N
NX
OH
N
N
N
N
NR
SOCl2Et3N, BuOH
R1Br
N
HN
N
N
NRO
R1R2
R1 = R2 = H
R2
1. I2, NaHCO32. Bu3Sn
HBr, AcOH
![Page 34: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/34.jpg)
34
Formation of bond d - Initial attempts
Vik et al.Tetrahedron. Lett. 2007, 48, 1931
Co-complex
NCo
N
N
N
OH2
O O
O
H
OH
N
N N
N
NR
R'' R'
N
N N
N
NR
R'' R'
RCM ?
7
d
N
N N
N
Cl
HXCH2CH=CH2
Pyridine, 100 oCN
N N
N
X
a: X = NH, 89%b: X = NMe, 92%c: X = Od: X = NBoc, 65%
(Boc)2ODMAP, CH2Cl2
N
N N
N
NBocGrubbs II or
Hoveyda-Grubbs II
DCE, Δ
54% (Grubbs II) 73% (How.-Grubbs II) Compds a-c: n.r.
N
N N
N
HN
HCl(aq)
MeOH81%
N
N N
N
HN
N
N NH
N
Cl I-CH2CH=CH2, K2CO3, Co-complex, CH3CN
(c.f. Dalby et al. Angew. Chem. Int. Ed. Engl. 1993, 32, 1696)
8
H2, Pd/C
H2SO2MeOH
85%
![Page 35: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/35.jpg)
35
N
N N
N
NR
R'' R'
N
N N
N
NR
R'' R'
RCM ?
7
N
N N
N
NH
(Boc)2O, DMAP
MeCN
Hoveyda-Grubbs II
DCE, ΔN
N N
N
NH
N
N N
N
NBoc
68%
N
N N
N
NBoc7
95%
K2CO3
MeCN, Δ
100%
N
N N
N
HN
76%
1) H2, Pd/C, EtOAc
2) HCl, MeOH
Vik et al.
Tetrahedron. Lett. 2007, 48, 1931
N
N N
N
HN
H
Asmarine H
![Page 36: 1 Synthesis directed towards Agelasines, Agelasimines, Asmarines and Analogs; Bioactive Marine Natural Products Lise-Lotte Gundersen Department of Chemistry,](https://reader035.vdocument.in/reader035/viewer/2022062518/56649f1e5503460f94c35abf/html5/thumbnails/36.jpg)
36
Acknowledgements
Synthesis•Dr. Anne Kristin Bakkestuen
•Anthony James
•Dr. Agnes Prozenyak
•Heidi Roggen
•Linda W. Tangen
•Dr. Bibigul T. Utenova
•Dr. Anders Vik
Bioactivities•Prof. Lars Bohlin & co-workers
•Dr. Colin Charnock•Tuberculosis Antimicrobial Acquisition & Coordinating Facility (TAACF)
•WHO - TDR
Financial Support•NFR (FRINAT & KOSK)
•UiO